Document is current

Any future updates will be listed below

Correction to: Investigation of satisfaction with short‑term outcomes after switching to faricimab to treat neovascular age‑related macular degeneration

Crossref DOI link: https://doi.org/10.1007/s10384-023-01035-1

Published Online: 2023-11-10

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark